Among Leading Medical Journals, It's NEJM That Sets The Citation Pace

Among the numerous medical journals published worldwide, it is The New England Journal of Medicine that can lay claim to having the greatest impact, at least in terms of citations. The annual impact factors for The New England Journal of Medicine, the Lancet, Annals of Internal Medicine, The Journal of the American Medical Association, The British Medical Journal and thousands of other medical and scientific journals are calculated each year by the Institute for Scientific Information (ISI).

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Among the numerous medical journals published worldwide, it is The New England Journal of Medicine that can lay claim to having the greatest impact, at least in terms of citations.

The annual impact factors for The New England Journal of Medicine, the Lancet, Annals of Internal Medicine, The Journal of the American Medical Association, The British Medical Journal and thousands of other medical and scientific journals are calculated each year by the Institute for Scientific Information (ISI). Impact is a measure of the degree to which a journal’s articles are cited, on average, in the scientific literature. It is an approximation of a journal’s influence.

To determine a journal’s impact, ISI counts citations from all journals during a given year to the articles published in that journal over the previous two years and divides that figure by the total number of articles published in that journal in those two years. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies